PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2016

Contribution of dermal-derived mesenchymal cells during liver repair in two different experimental models.

Mouse / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 27126764 ↗2016Reported benefit

Contribution of dermal-derived mesenchymal cells during liver repair in two different experimental models.

MouseChemical/toxinC57BL/6J recipients; EGFP-transgenic CByJ.B6-Tg(CAG-EGFP)1Osb/J donorsMale recipients; donor sex not statedHepatic portal vein (fibrosis model); tail vein (irradiation model)Week 6 of a 10 week CCl4 regimen; 4 h after 8 Gy total-body irradiation

Model: CCl4-induced liver fibrosis (0.6 ml/kg intraperitoneally twice weekly for 10 weeks) and 8 Gy lethal total-body irradiation

DMCs transplantation reduced CCl4-induced fibrosis and restored liver function, and improved survival after 8 Gy total-body irradiation, with long-term hepatic engraftment of a macrophage-like DMC population.

Extraction: extract · Supplied extraction confidence: 0.85. Machine-extracted fields require source verification.